Search
for

    Did you mean Anagen Effluvium?
    GlossaryAnagen Effluvium

    sudden hair loss during the growth phase, often from chemotherapy

    Anagen Effluvium is a type of hair loss that occurs during the anagen phase, or growth phase, of the hair cycle. It is often caused by factors that disrupt the rapidly dividing cells in hair follicles, such as chemotherapy, radiation therapy, or exposure to toxic chemicals. This condition leads to sudden and widespread hair shedding, primarily affecting the scalp but potentially other body hair as well.

    Related Terms

    Learn

    5 / 17 results

      learn Exosomes

      Microscopic delivery system that sends growth-promoting signals to hair follicles

      learn Fluridil

      a topical anti-androgen with less systemic involvement

      learn Ketoconazole

      antifungal with some anti-androgenic benefits, often used as a shampoo

      learn Latanoprost

      glaucoma medication with hair follicle stimulant effects

    Research

    5 / 1000+ results
      Alopecia: A Pathologist's View

      research Alopecia: A Pathologist's View

      23 citations, July 1982 in “International Journal of Dermatology”
      The review concludes that accurate diagnosis of different types of hair loss requires proper biopsy techniques and understanding the hair growth cycle and underlying causes.
      Study of Diffuse Alopecia in Females

      research Study of Diffuse Alopecia in Females

      9 citations, March 2000 in “PubMed”
      Most women in the study lost hair due to stress, fever, childbirth, surgery, or thyroid issues, with low hemoglobin levels also common.
      Histopathology of Non-Scarring Alopecia

      research Histopathology of Non-Scarring Alopecia

      122 citations, April 1995 in “Journal of Cutaneous Pathology”
      The document describes how to tell different types of non-scarring hair loss apart by looking at hair and scalp tissue under a microscope.
      Evaluation of Alopecia

      research Evaluation of Alopecia

      1 citations, March 1995 in “JAMA”
      The woman's hair loss is likely stress-related and should improve without treatment.

    Community Join

    5 / 246 results

      community Anagen is now selling pyrilutamide

      in Product  138 upvotes 2 years ago
      Pyrilutamide, a potential hair loss treatment that has recently been released for sale, and is thought to have similar efficacy to Dutasteride without side effects. It was discussed in terms of its effectiveness compared to Finasteride, its use by females, and whether it can be safely mixed with RU58841.

      community Bad news about GT20029 from Anagen Inc

      in Treatment  10 upvotes 1 year ago
      The conversation is about the difficulty in obtaining GT20029, a hair loss treatment, due to patent issues and the need to resort to group buys or Chinese labs for acquisition. Specific treatments mentioned include Minoxidil, finasteride, and RU58841.

      community Looking for the new RU58841 source in EU

      in Product 6 months ago
      The user is seeking a new source for RU58841 in the EU after their previous supplier stopped selling it. They mention considering Anagen, Actifolic, Minoxidilmax, and rudirect, and ask for advice on shipping within the EU and product quality, while also mentioning their current hair loss treatment involves mixing RU with Stemoxydine and Alfatradiol.

      community Looking for the new RU58841 source in EU

      in Treatment  7 upvotes 6 months ago
      A user is seeking a new source for RU58841 in the EU after their previous supplier stopped selling it. They mention considering Anagen, Actifolic, Minoxidilmax, and rudirect, and are using a treatment mixing RU58841 with Stemoxydine and Alfatradiol.

      community Looking for the new RU58841 source in EU

      in Treatment  4 upvotes 6 months ago
      A user is seeking a new source for RU58841 in the EU after their previous supplier stopped selling it. They mention considering Anagen, Actifolic, Minoxidilmax, and rudirect, and are using a treatment mixing RU58841 with Stemoxydine and Alfatradiol.